|
Report of Ernst & Young LLP, Independent Registered Public Accounting Firm (PCAOB ID: 42)
|
2
|
|
Consolidated Balance Sheets as of January 31, 2026 and February 1, 2025
|
5
|
|
Consolidated Statements of Operations for the 52 Weeks Ended January 31, 2026 and February 1, 2025 and the 53 Weeks Ended February 3, 2024
|
6
|
|
Consolidated Statements of Shareholders’ (Deficit) Equity for the 52 Weeks Ended January 31, 2026 and February 1, 2025 and the 53 Weeks Ended February 3, 2024
|
7
|
|
Consolidated Statements of Cash Flows for the 52 Weeks Ended January 31, 2026 and February 1, 2025 and the 53 Weeks Ended February 3, 2024
|
8
|
|
Notes to Consolidated Financial Statements
|
9
|
![]() |
Ernst & Young LLP
222 2nd Avenue South
Suite 2100
Nashville, TN 37201
|
Tel: +1 615 252-2000
ey.com
|
![]() |
|
Estimate of Self-Insurance Reserves
|
||
|
Description of
the Matter
|
At January 31, 2026, the Company’s reserves for self-insurance risks was $3.7 million, net of estimated stop-loss insurance receivables. As
discussed in Note 1 of the consolidated financial statements, the Company retains a significant portion of risk for loss exposure for claims. Accordingly, provisions are recorded based upon periodic estimates of such losses, as determined
by management. The future cost for the claims exposure is estimated using actuarial methods that consider assumptions for a number of factors including, but not limited to, historical claims experience and loss development factors.
Auditing management’s estimate of certain self-insurance reserves was complex and judgmental due to the significant assumptions and
judgments required by management to project the exposure for incurred claims that remain unresolved, including those which have been incurred but not yet reported to the Company.
|
|
|
How We Addressed the Matter in Our Audit
|
To test the Company’s estimate of certain self-insurance reserves, we performed audit procedures that included, among others, assessing the actuarial valuation methodologies
utilized by management, testing the significant assumptions described above, testing the related underlying data used by the Company in its evaluation for completeness and accuracy, and testing the mathematical accuracy of the
calculations. Our audit procedures also included, among others, comparing the significant assumptions used by management to industry accepted actuarial assumptions and reassessing the accuracy of management’s historical estimates utilized
in prior period evaluations. We involved our actuarial valuation specialists to assist in assessing the valuation methodologies and significant assumptions noted above and to develop an independent range of estimates for certain
self-insurance reserves which we then compared to management’s estimates.
|
![]() |
|
Estimate of Collaboration Agreement Fees Debt
|
||
|
Description of the Matter
|
As described in Note 1 and 5 to the consolidated financial statements, the sale of a percentage of the Company’s future revenue to Bed Bath
& Beyond, Inc. under the Collaboration Agreement (modified in May 2025), have been accounted for as debt financing and the Company has recorded a liability of $6.6 million as of January 31, 2026, which is included in current related
party debt and related party debt, net on the consolidated balance sheet. The liability will be accreted to the total of the payments as interest expense using the effective interest method over the life of the Collaboration Agreement.
The Company will periodically assess the estimated payments to Bed Bath & Beyond, Inc. and to the extent the amount or timing of such fees is materially different than the original estimates, an adjustment will be recorded
prospectively to increase or decrease interest expense.
Auditing the Collaboration Agreement fees debt was judgmental due to the estimation uncertainty in determining the future revenue included
in the effective interest rate model, which is affected by future market conditions.
|
|
|
How We Addressed the Matter in Our Audit
|
To test the Company’s modified Collaboration Agreement fees debt, our audit procedures included, among others, assessing the projections of future revenue. We compared the
future revenue to historical revenue and current industry, market and economic trends. We recalculated interest expense based on the amortization schedules and estimates of cash payments using the effective interest method and performed
sensitivity analyses to evaluate the changes in the Collaboration Agreement fees debt, and associated interest expense, that would result from changes in future revenue.
|
|
January 31, 2026
|
February 1, 2025
|
|||||||
|
(In thousands, except share data)
|
||||||||
|
ASSETS
|
||||||||
|
Current assets:
|
||||||||
|
Cash and cash equivalents
|
$
|
2,932
|
$
|
3,820
|
||||
|
Inventories, net
|
58,758
|
81,899
|
||||||
|
Prepaid expenses and other current assets
|
7,049
|
5,585
|
||||||
|
Total current assets
|
68,739
|
91,304
|
||||||
|
Property and equipment:
|
||||||||
|
Equipment
|
18,017
|
18,905
|
||||||
|
Furniture and fixtures
|
53,749
|
61,354
|
||||||
|
Leasehold improvements
|
85,825
|
97,635
|
||||||
|
Computer software and hardware
|
77,784
|
78,847
|
||||||
|
Projects in progress
|
343
|
287
|
||||||
|
Property and equipment, gross
|
235,718
|
257,028
|
||||||
|
Accumulated depreciation
|
(221,008
|
)
|
(234,966
|
)
|
||||
|
Property and equipment, net
|
14,710
|
22,062
|
||||||
|
Operating lease right-of-use assets
|
102,280
|
121,229
|
||||||
|
Other assets
|
2,604
|
7,593
|
||||||
|
Total assets
|
$
|
188,333
|
$
|
242,188
|
||||
|
LIABILITIES AND SHAREHOLDERS’ DEFICIT
|
||||||||
|
Current liabilities:
|
||||||||
|
Accounts payable
|
$
|
55,348
|
$
|
43,935
|
||||
|
Accrued expenses and other liabilities
|
17,893
|
20,183
|
||||||
|
Operating lease liabilities
|
33,821
|
39,355
|
||||||
|
Current debt, net
|
—
|
49,199
|
||||||
|
Current related party debt
|
1,361
|
—
|
||||||
|
Total current liabilities
|
108,423
|
152,672
|
||||||
|
Operating lease liabilities
|
78,185
|
95,085
|
||||||
|
Long-term debt, net
|
15,986
|
10,003
|
||||||
|
Related party debt, net
|
36,444
|
—
|
||||||
|
Other liabilities
|
3,172
|
3,445
|
||||||
|
Total liabilities
|
242,210
|
261,205
|
||||||
|
Commitments and contingencies (Note 10)
|
—
|
—
|
||||||
|
Shareholders’ (deficit) equity:
|
||||||||
|
Preferred stock, no par value, 10,000,000 shares authorized; no shares issued or outstanding at January 31, 2026, and
February 1, 2025
|
—
|
—
|
||||||
|
Common stock, no par value, 80,000,000 and 100,000,000 shares authorized; 22,461,383 and 13,117,942 shares issued and
outstanding at January 31, 2026, and February 1, 2025, respectively
|
188,549
|
177,543
|
||||||
|
Accumulated deficit
|
(242,426
|
)
|
(196,560
|
)
|
||||
|
Total shareholders’ deficit
|
(53,877
|
)
|
(19,017
|
)
|
||||
|
Total liabilities and shareholders’ deficit
|
$
|
188,333
|
$
|
242,188
|
||||
|
52 Weeks
Ended January
31, 2026
|
52 Weeks
Ended
February 1, 2025
|
53 Weeks
Ended
February 3, 2024
|
||||||||||
|
(In thousands, except per share data)
|
||||||||||||
|
Net sales
|
$
|
395,782
|
$
|
441,360
|
$
|
468,690
|
||||||
|
Cost of sales
|
310,709
|
319,354
|
341,700
|
|||||||||
|
Gross profit
|
85,073
|
122,006
|
126,990
|
|||||||||
|
Operating expenses:
|
||||||||||||
|
Compensation and benefits
|
76,816
|
77,722
|
82,152
|
|||||||||
|
Other operating expenses
|
53,639
|
54,699
|
62,863
|
|||||||||
|
Depreciation (exclusive of depreciation included in cost of sales)
|
2,319
|
3,509
|
4,522
|
|||||||||
|
Gain on sale of internally developed intangible assets
|
(10,000
|
)
|
—
|
—
|
||||||||
|
Asset impairment
|
2,013
|
109
|
1,867
|
|||||||||
|
Total operating expenses
|
124,787
|
136,039
|
151,404
|
|||||||||
|
Operating loss
|
(39,714
|
)
|
(14,033
|
)
|
(24,414
|
)
|
||||||
|
Interest expense
|
6,024
|
5,949
|
3,317
|
|||||||||
|
Loss on extinguishment of debt
|
—
|
3,338
|
—
|
|||||||||
|
Other income
|
(230
|
)
|
(504
|
)
|
(499
|
)
|
||||||
|
Loss before income taxes
|
(45,508
|
)
|
(22,816
|
)
|
(27,232
|
)
|
||||||
|
Income tax expense
|
358
|
316
|
519
|
|||||||||
|
Net loss
|
$
|
(45,866
|
)
|
$
|
(23,132
|
)
|
$
|
(27,751
|
)
|
|||
|
Loss per share:
|
||||||||||||
|
Basic
|
$
|
(2.05
|
)
|
$
|
(1.77
|
)
|
$
|
(2.16
|
)
|
|||
|
Diluted
|
$
|
(2.05
|
)
|
$
|
(1.77
|
)
|
$
|
(2.16
|
)
|
|||
|
Weighted average shares outstanding:
|
||||||||||||
|
Basic
|
22,369
|
13,068
|
12,871
|
|||||||||
|
Diluted
|
22,369
|
13,068
|
12,871
|
|||||||||
|
Common Stock
|
Accumulated
Deficit
|
Total
Shareholders’
(Deficit)
Equity
|
||||||||||||||
|
Shares
|
Amount
|
|||||||||||||||
|
(In thousands, except share data)
|
||||||||||||||||
|
Balance at January 28, 2023
|
12,754,368
|
$
|
175,450
|
$
|
(145,677
|
)
|
$
|
29,773
|
||||||||
|
Restricted stock issued
|
202,967
|
—
|
—
|
—
|
||||||||||||
|
Net share settlement of restricted stock units
|
(31,313
|
)
|
(84
|
)
|
—
|
(84
|
)
|
|||||||||
|
Stock-based compensation expense
|
—
|
1,186
|
—
|
1,186
|
||||||||||||
|
Net loss
|
—
|
—
|
(27,751
|
)
|
(27,751
|
)
|
||||||||||
|
Balance at February 3, 2024
|
12,926,022
|
176,552
|
(173,428
|
)
|
3,124
|
|||||||||||
|
Restricted stock issued
|
215,591
|
—
|
—
|
—
|
||||||||||||
|
Net share settlement of restricted stock units
|
(23,671
|
)
|
(51
|
)
|
—
|
(51
|
)
|
|||||||||
|
Stock-based compensation expense
|
—
|
1,042
|
—
|
1,042
|
||||||||||||
|
Net loss
|
—
|
—
|
(23,132
|
)
|
(23,132
|
)
|
||||||||||
|
Balance at February 1, 2025
|
13,117,942
|
177,543
|
(196,560
|
)
|
(19,017
|
)
|
||||||||||
|
Restricted stock issued
|
141,006
|
—
|
—
|
—
|
||||||||||||
|
Net share settlement of restricted stock units
|
(42,165
|
)
|
(55
|
)
|
—
|
(55
|
)
|
|||||||||
|
Issuance of common stock to Bed Bath & Beyond, Inc. for subscription agreement
|
4,324,324
|
7,730
|
—
|
7,730
|
||||||||||||
|
Issuance of common stock to convert term loan and accrued interest
|
4,610,141
|
6,705
|
—
|
6,705
|
||||||||||||
|
Issuance of common stock to Consensus Securities LLC for subscription agreement
|
310,135
|
—
|
—
|
—
|
||||||||||||
|
Stock-based compensation expense
|
—
|
645
|
—
|
645
|
||||||||||||
|
Loss on debt extinguishment from a related party
|
—
|
(4,019
|
)
|
—
|
(4,019
|
)
|
||||||||||
|
Net loss
|
—
|
—
|
(45,866
|
)
|
(45,866
|
)
|
||||||||||
|
Balance at January 31, 2026
|
22,461,383
|
$
|
188,549
|
$
|
(242,426
|
)
|
$
|
(53,877
|
)
|
|||||||
|
52 Weeks Ended
January 31, 2026
|
52 Weeks Ended
February 1, 2025
|
53 Weeks Ended
February 3, 2024
|
||||||||||
|
(In thousands)
|
||||||||||||
|
Cash flows from operating activities:
|
||||||||||||
|
Net loss
|
$
|
(45,866
|
)
|
$
|
(23,132
|
)
|
$
|
(27,751
|
)
|
|||
|
Adjustments to reconcile net loss to net cash used in operating activities:
|
||||||||||||
|
Depreciation of property and equipment
|
8,242
|
9,745
|
11,980
|
|||||||||
|
Amortization of debt issuance costs and original issue discount costs
|
1,873
|
898
|
124
|
|||||||||
|
Asset impairment
|
2,013
|
109
|
1,867
|
|||||||||
|
Loss on disposal of property and equipment
|
290
|
17
|
9
|
|||||||||
|
Stock-based compensation expense
|
645
|
1,042
|
1,186
|
|||||||||
|
Loss on extinguishment of debt
|
—
|
3,338
|
—
|
|||||||||
|
Gain on disposal of internally developed intangible assets
|
(10,000
|
)
|
—
|
—
|
||||||||
|
Changes in assets and liabilities:
|
||||||||||||
|
Inventories, net
|
23,141
|
(7,809
|
)
|
9,981
|
||||||||
|
Prepaid expenses and other current assets
|
(1,464
|
)
|
2,018
|
(2,525
|
)
|
|||||||
|
Accounts payable
|
11,595
|
(1,886
|
)
|
2,186
|
||||||||
|
Accrued expenses and other liabilities
|
(3,080
|
)
|
(2,500
|
)
|
(3,146
|
)
|
||||||
|
Operating lease assets and liabilities
|
(3,759
|
)
|
100
|
(8,585
|
)
|
|||||||
|
Other assets and liabilities
|
4,469
|
(1,191
|
)
|
198
|
||||||||
|
Net cash used in operating activities
|
(11,901
|
)
|
(19,251
|
)
|
(14,476
|
)
|
||||||
|
Cash flows from investing activities:
|
||||||||||||
|
Proceeds from sale of property and equipment
|
(111
|
)
|
38
|
148
|
||||||||
|
Proceeds from sale of internally developed intangible assets
|
10,000
|
—
|
—
|
|||||||||
|
Capital expenditures
|
(2,814
|
)
|
(2,390
|
)
|
(4,779
|
)
|
||||||
|
Net cash provided by (used in) investing activities
|
7,075
|
(2,352
|
)
|
(4,631
|
)
|
|||||||
|
Cash flows from financing activities:
|
||||||||||||
|
Borrowings on revolving line of credit
|
343,162
|
45,100
|
64,000
|
|||||||||
|
Repayments on revolving line of credit
|
(370,176
|
)
|
(36,100
|
)
|
(45,000
|
)
|
||||||
|
Borrowings on FILO term loan
|
—
|
10,000
|
—
|
|||||||||
|
Repayments on FILO term loan
|
—
|
(10,000
|
)
|
—
|
||||||||
|
Payment of prepayment penalties on extinguishment of debt
|
—
|
(2,638
|
)
|
—
|
||||||||
|
Proceeds from Bed Bath & Beyond, Inc. term loan transactions
|
24,436
|
17,000
|
—
|
|||||||||
|
Payments of debt and equity issuance costs
|
(1,429
|
)
|
(1,693
|
)
|
(1,175
|
)
|
||||||
|
Cash used in net share settlement of stock options and restricted stock units
|
(55
|
)
|
(51
|
)
|
(84
|
)
|
||||||
|
Proceeds from issuance of common stock
|
8,000
|
—
|
—
|
|||||||||
|
Net cash provided by financing activities
|
3,938
|
21,618
|
17,741
|
|||||||||
|
Cash and cash equivalents:
|
||||||||||||
|
Net (decrease) increase
|
(888
|
)
|
15
|
(1,366
|
)
|
|||||||
|
Beginning of the year
|
3,820
|
3,805
|
5,171
|
|||||||||
|
End of the year
|
$
|
2,932
|
$
|
3,820
|
$
|
3,805
|
||||||
|
Supplemental cash flow information:
|
||||||||||||
|
Interest paid
|
$
|
4,076
|
$
|
4,795
|
$
|
3,290
|
||||||
|
Income taxes paid
|
350
|
335
|
561
|
|||||||||
|
Supplemental schedule of non-cash activities:
|
||||||||||||
|
Non-cash accruals for purchases of property and equipment
|
$
|
363
|
$
|
369
|
$
|
504
|
||||||
|
Non-cash accruals for debt issuance costs
|
673
|
534
|
1,180
|
|||||||||
|
Increase in operating lease liabilities from new or modified leases
|
9,399
|
29,289
|
28,563
|
|||||||||
|
Conversion of convertible note, accrued interest and unamortized debt issuance costs into common stock
|
6,705
|
—
|
—
|
|||||||||
|
Common stock issued in exchange for debt issuance costs
|
574
|
—
|
—
|
|||||||||
|
January 31,
2026
|
February 1,
2025
|
February 3,
2024
|
||||||||||
|
Gift card liability, net of estimated breakage (included in accrued expenses and other liabilities)
|
$
|
9,363
|
$
|
10,673
|
$
|
12,008
|
||||||
|
52 Weeks
Ended January
31, 2026
|
52 Weeks
Ended
February 1,
2025
|
53 Weeks
Ended
February 3,
2024
|
||||||||||
|
Gift card breakage revenue (included in net sales)
|
$
|
949
|
$
|
1,120
|
$
|
2,195
|
||||||
|
Gift card redemptions recognized in the current period related to amounts included in the gift card contract liability
balance as of the prior period
|
3,234
|
3,962
|
4,800
|
|||||||||
|
January 31,
2026
|
February 1,
2025
|
|||||||
|
Gift cards
|
$
|
9,363
|
$
|
10,673
|
||||
|
Salaries and wages
|
1,949
|
1,616
|
||||||
|
Workers’ compensation and general liability reserves
|
1,803
|
1,981
|
||||||
|
Loyalty program deferred revenue
|
1,159
|
1,493
|
||||||
|
Sales taxes
|
1,068
|
1,131
|
||||||
|
Sales returns reserve
|
699
|
1,046
|
||||||
|
Deferred e-commerce revenue
|
309
|
607
|
||||||
|
Employee medical insurance reserves
|
272
|
392
|
||||||
|
Other
|
1,271
|
1,244
|
||||||
|
$
|
17,893
|
$
|
20,183
|
|||||
|
52 Weeks
Ended January
31, 2026
|
52 Weeks
Ended
February 1,
2025
|
53 Weeks
Ended
February 3,
2024
|
||||||||||
|
Current tax expense:
|
||||||||||||
|
Federal
|
$
|
—
|
$
|
—
|
$
|
46
|
||||||
|
State
|
358
|
316
|
473
|
|||||||||
|
Income tax expense
|
$
|
358
|
$
|
316
|
$
|
519
|
||||||
|
52 Weeks
Ended
January 31,
2026
|
52 Weeks
Ended
February 1,
2025
|
53 Weeks
Ended
February 3,
2024
|
||||||||||||||||||||||
|
Tax at federal statutory rate
|
$
|
(9,557
|
)
|
21.0
|
%
|
$
|
(4,791
|
)
|
21.0
|
%
|
$
|
(5,719
|
)
|
21.0
|
%
|
|||||||||
|
State income taxes, net of federal benefit (1)
|
(323
|
)
|
0.7
|
%
|
(133
|
)
|
0.6
|
%
|
(293
|
)
|
1.1
|
%
|
||||||||||||
|
Tax credits
|
(61
|
)
|
0.1
|
%
|
(87
|
)
|
0.4
|
%
|
(107
|
)
|
0.4
|
%
|
||||||||||||
|
Executive compensation
|
—
|
0.0
|
%
|
—
|
0.0
|
%
|
(23
|
)
|
0.1
|
%
|
||||||||||||||
|
Stock based compensation programs
|
159
|
-0.3
|
%
|
111
|
-0.5
|
%
|
209
|
-0.8
|
%
|
|||||||||||||||
|
Changes in valuation allowances
|
10,130
|
-22.3
|
%
|
5,205
|
-22.8
|
%
|
6,399
|
-23.5
|
%
|
|||||||||||||||
|
Other
|
10
|
0.0
|
%
|
11
|
-0.1
|
%
|
53
|
-0.2
|
%
|
|||||||||||||||
|
Income tax expense
|
$
|
358
|
-0.8
|
%
|
$
|
316
|
-1.4
|
%
|
$
|
519
|
-1.9
|
%
|
||||||||||||
|
(1)
|
State taxes in California and Illinois for tax years January 31, 2026 and February 1, 2025 and Tennessee for tax year ended February 3, 2024 made up the
majority (greater than 50%) of the tax effect in this category.
|
|
52 Weeks
Ended January
31, 2026
|
52 Weeks
Ended
February 1,
2025
|
53 Weeks
Ended
February 3,
2024 |
||||||||||
|
Federal
|
$
|
—
|
$
|
(57
|
)
|
$
|
(73
|
)
|
||||
|
State
|
350
|
392
|
634
|
|||||||||
|
Total
|
$
|
350
|
$
|
335
|
$
|
561
|
||||||
|
52 Weeks
Ended January
31, 2026
|
52 Weeks
Ended
February 1,
2025
|
53 Weeks
Ended
February 3,
2024
|
||||||||||
|
Texas
|
$
|
117
|
$
|
123
|
$
|
143
|
||||||
|
Tennessee
|
69
|
35
|
75
|
|||||||||
|
Florida
|
23
|
36
|
37
|
|||||||||
|
Pennsylvania
|
21
|
30
|
59
|
|||||||||
|
Georgia
|
20
|
30
|
58
|
|||||||||
|
Alabama
|
18
|
21
|
•
|
|||||||||
|
Indiana
|
•
|
16
|
29
|
|||||||||
|
Virginia
|
•
|
16
|
•
|
|||||||||
|
South Carolina
|
•
|
15
|
•
|
|||||||||
|
Louisiana
|
•
|
•
|
28
|
|||||||||
|
•
|
Jurisdiction below the threshold for the period presented.
|
|
January 31,
2026
|
February 1,
2025
|
|||||||
|
Deferred tax assets:
|
||||||||
|
Operating lease liabilities
|
$
|
27,878
|
$
|
33,865
|
||||
|
Accruals
|
1,417
|
1,741
|
||||||
|
Inventory valuation
|
236
|
343
|
||||||
|
Federal and state tax credit carryforwards
|
223
|
206
|
||||||
|
Federal and state net operating loss carryforwards
|
27,650
|
18,433
|
||||||
|
Other
|
6,342
|
5,770
|
||||||
|
Total deferred tax assets
|
63,746
|
60,358
|
||||||
|
Valuation allowance for deferred tax assets
|
(36,394
|
)
|
(26,302
|
)
|
||||
|
Net deferred tax assets
|
27,352
|
34,056
|
||||||
|
Deferred tax liabilities:
|
||||||||
|
Property and equipment
|
(1,280
|
)
|
(2,939
|
)
|
||||
|
Operating lease right-of-use assets
|
(25,632
|
)
|
(30,574
|
)
|
||||
|
Prepaid assets
|
(440
|
)
|
(543
|
)
|
||||
|
Total deferred tax liabilities
|
(27,352
|
)
|
(34,056
|
)
|
||||
|
Net deferred tax assets
|
$
|
—
|
$
|
—
|
||||
|
January 31, 2026
|
February 1, 2025
|
||||||||||||||||
|
Fair Value
Hierarchy
|
Carrying Value (1)
|
Fair Value
|
Carrying Value
|
Fair Value
|
|||||||||||||
|
Non-Convertible Term Loan (2)
|
Level 2
|
$
|
—
|
$
|
—
|
$
|
5,531
|
$
|
7,980
|
||||||||
|
Convertible Term Loan (2)
|
Level 2
|
—
|
—
|
6,676
|
7,003
|
||||||||||||
|
Beyond Term Loan (2)
|
Level 2
|
31,185
|
28,612
|
—
|
—
|
||||||||||||
|
Collaboration Agreement fees (3)
|
Level 3
|
6,620
|
5,639
|
3,995
|
5,439
|
||||||||||||
|
(1)
|
See “Note 5 — Long-Term Debt” for further discussion of the carrying values, which is shown on a net basis herein of unamortized debt discount and issuance
costs.
|
|
(2)
|
The fair value was estimated using available market information for debt instruments with similar maturities and credit risk.
|
|
(3)
|
The fair value estimate uses the Company’s estimated future revenue projections over the term of the Collaboration Agreement discounted using current
market rates for debt investments with similar maturities and credit risk.
|
|
January 31, 2026
|
||||
|
Beyond Term Loan
|
$
|
33,732
|
||
|
Collaboration Agreement fees
|
6,620
|
|||
|
Total outstanding related party borrowings
|
40,352
|
|||
|
Less: unamortized debt discount and issuance costs
|
(2,547
|
)
|
||
|
Total related party debt
|
37,805
|
|||
|
Less: current portion of related party debt
|
(1,361
|
)
|
||
|
Related party debt, net
|
$
|
36,444
|
||
|
January 31, 2026
|
February 1, 2025
|
|||||||
|
Revolving line of credit
|
$
|
15,986
|
$
|
43,000
|
||||
|
Non-Convertible Term Loan
|
—
|
8,500
|
||||||
|
Convertible Term Loan
|
—
|
8,500
|
||||||
|
Collaboration Agreement fees
|
—
|
3,995
|
||||||
|
Total outstanding borrowings
|
15,986
|
63,995
|
||||||
|
Less: unamortized debt discount and issuance costs
|
—
|
(4,793
|
)
|
|||||
|
Total debt
|
15,986
|
59,202
|
||||||
|
Less: current portion of long-term debt
|
—
|
(49,199
|
)
|
|||||
|
Long-term debt, net
|
$
|
15,986
|
$
|
10,003
|
||||
|
Scheduled
Maturities
|
||||
|
2026
|
$
|
1,471
|
||
|
2027
|
1,378
|
|||
|
2028
|
1,378
|
|||
|
2029
|
51,096
|
|||
|
2030
|
1,378
|
|||
|
Thereafter
|
1,378
|
|||
|
Total scheduled maturities
|
58,079
|
|||
|
Less: unamortized debt discount and issuance costs
|
(2,547
|
)
|
||
|
Less: present value of collaboration agreement fees
|
(3,267
|
)
|
||
|
Total debt
|
$
|
52,265
|
||
|
52 Week Period
Ended (1)
|
52 Week Period
Ended (1)
|
53 Week Period
Ended (1)
|
||||||||||
|
January 31, 2026
|
February 1, 2025
|
February 3, 2024
|
||||||||||
|
Cost of sales (2)
|
||||||||||||
|
Operating lease cost
|
$
|
44,955
|
$
|
45,373
|
$
|
46,066
|
||||||
|
Short-term lease cost
|
783
|
743
|
1,308
|
|||||||||
|
Variable lease cost
|
641
|
1,067
|
1,226
|
|||||||||
|
Total lease cost in cost of sales
|
46,379
|
47,183
|
48,600
|
|||||||||
|
Other operating expenses
|
||||||||||||
|
Operating lease cost
|
1,197
|
1,201
|
1,651
|
|||||||||
|
Short-term lease cost
|
57
|
63
|
66
|
|||||||||
|
Total lease cost in other operating expenses
|
1,254
|
1,264
|
1,717
|
|||||||||
|
Total lease cost
|
$
|
47,633
|
$
|
48,447
|
$
|
50,317
|
||||||
|
(1)
|
Total lease cost excludes expense for non-lease components including common area maintenance and excludes costs that are not a component of the lease
including insurance, taxes and utilities for the Company’s leases.
|
|
(2)
|
Cost of sales includes all distribution center lease costs and store occupancy-related lease costs.
|
|
Operating
Leases |
||||
|
2026
|
$
|
42,717
|
||
|
2027
|
34,820
|
|||
|
2028
|
24,829
|
|||
|
2029
|
16,327
|
|||
|
2030
|
8,898
|
|||
|
Thereafter
|
8,344
|
|||
|
Total lease payments
|
135,935
|
|||
|
Less: interest
|
(23,929
|
)
|
||
|
Present value of lease liabilities
|
$
|
112,006
|
||
|
January 31,
2026
|
||||
|
Weighted-average remaining lease term (years)
|
4.2
|
|||
|
Weighted-average discount rate
|
9.8
|
%
|
||
|
52 Weeks Ended
January 31, 2026
|
52 Weeks Ended
February 1, 2025
|
53 Weeks Ended
February 3, 2024
|
||||||||||
|
Operating cash flows from operating leases
|
$
|
45,381
|
$
|
46,122
|
$
|
55,805
|
||||||
|
Shares
|
Weighted
Average Grant Date
Fair Value
|
|||||||
|
Non-Vested at January 31, 2026
|
517,151
|
$
|
2.77
|
|||||
|
Granted
|
1,983,772
|
1.52
|
||||||
|
Vested
|
(141,006
|
)
|
3.36
|
|||||
|
Forfeited
|
(595,660
|
)
|
1.72
|
|||||
|
Non-Vested at February 1, 2025
|
1,764,257
|
$
|
1.67
|
|||||
|
52 Weeks
Ended January
31, 2026
|
52 Weeks
Ended
February 1,
2025
|
53 Weeks
Ended
February 3,
2024
|
||||||||||
|
Weighted average grant date fair value of RSUs (per share)
|
$
|
1.52
|
$
|
2.29
|
$
|
2.83
|
||||||
|
Total fair value of restricted stock units vested (in thousands)
|
$
|
183
|
$
|
455
|
$
|
560
|
||||||
|
Number of
Options
|
Weighted
Average
Exercise
Price
|
Weighted Average
Remaining
Contractual
Term (in years)
|
Aggregate
Intrinsic
Value (in
thousands)
|
|||||||||||||
|
Balance at February 1, 2025
|
441,309
|
$
|
4.45
|
|||||||||||||
|
Options granted
|
—
|
|||||||||||||||
|
Options forfeited
|
(68,086
|
)
|
3.32
|
|||||||||||||
|
Options expired
|
(148,676
|
)
|
5.63
|
|||||||||||||
|
Balance at January 31, 2026
|
224,547
|
$
|
4.00
|
7.5
|
$
|
—
|
||||||||||
|
Options Exercisable As of:
|
||||||||||||||||
|
January 31, 2026
|
88,000
|
$
|
4.33
|
6.8
|
$
|
—
|
||||||||||
|
52 Weeks
Ended January
31, 2026
|
52 Weeks
Ended
February 1,
2025
|
53 Weeks
Ended
February 3,
2024
|
||||||||||
|
Weighted average grant date fair value of options granted (per share)
|
$
|
—
|
$
|
1.82
|
$
|
2.06
|
||||||
|
Total fair value of stock options vested (in thousands)
|
$
|
211
|
$
|
235
|
$
|
57
|
||||||
|
Intrinsic value of stock options exercised (in thousands)
|
$
|
—
|
$
|
—
|
$
|
—
|
||||||
|
52 Weeks
Ended
February 1,
2025
|
53 Weeks
Ended
February 3,
2024
|
|||||||
|
Expected price volatility
|
93.5
|
%
|
92.4
|
%
|
||||
|
Risk-free interest rate
|
4.1
|
%
|
3.3
|
%
|
||||
|
Expected life (in years)
|
6
|
6
|
||||||
|
Dividend yield
|
0
|
%
|
0
|
%
|
||||
|
52 Weeks
Ended January
31, 2026 |
52 Weeks
Ended
February 1,
2025
|
53 Weeks
Ended
February 3,
2024
|
||||||||||
|
Impairment of leasehold improvements, fixtures and equipment at stores
|
$
|
1,739
|
$
|
109
|
$
|
648
|
||||||
|
Impairment of right-of-use assets
|
274
|
—
|
—
|
|||||||||
|
Impairment of software projects
|
—
|
—
|
676
|
|||||||||
|
Impairment of software as a service implementation costs
|
—
|
—
|
324
|
|||||||||
|
Impairment of e-commerce distribution center fixtures
|
—
|
—
|
95
|
|||||||||
|
Impairment of other long-lived assets
|
—
|
—
|
124
|
|||||||||
|
Total impairment
|
$
|
2,013
|
$
|
109
|
$
|
1,867
|
||||||
|
Number of stores with leasehold improvements, fixtures and equipment impairment
|
28
|
4
|
7
|
|||||||||